The World Health Organization recently declared that Covid-19 is no longer a global health emergency. While the pandemic threat has waned, there continues to be huge unmet need for affordable essential medicines to treat chronic diseases that kill 41 million people each year. Over the last two decades, Biocon has been at the forefront of … Continue reading Biocon Reports a Robust Business Performance in FY23
A Blog by Biocon 